— Know what they know.
Not Investment Advice
Also trades as: OGI.TO (TSX) · $vol 0M

OGI NASDAQ

Organigram Global Inc.
1W: -13.3% 1M: -19.9% 3M: -3.6% YTD: -44.9% 1Y: -50.1% 3Y: -28.9% 5Y: -90.2%
$0.95
-0.03 (-2.97%)
 
Weekly Expected Move ±6.0%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Sell · Power 29 · $134.2M mcap · 94M float · 0.832% daily turnover · Short 36% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$186M +16.4% ▲
5Y CAGR: +16.5%
Gross Profit
$7M -85.6% ▼
Operating Income
-$63M -77.7% ▼
Net Income
-$18M +60.9% ▲
EPS (Diluted)
$-0.14 +70.8% ▲
EBITDA
-$15M +37.4% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$79M$146M$149M$160M$186M
YoY Growth-8.8%+84.2%+2.3%+7.1%+16.4%
Cost of Revenue$108M$114M$114M$112M$179M
Gross Profit-$28M$32M$35M$48M$7M
Gross Margin-35.9%21.7%23.5%29.7%3.7%
R&D Expenses$3M$6M$12M$11M$11M
SG&A Expenses$46M$59M$72M$68M$87M
Operating Expenses$63M$75M$271M$83M$70M
Operating Income-$92M-$43M-$243M-$36M-$63M
Operating Margin-116.0%-29.6%-162.7%-22.3%-34.1%
Interest Expense$3M$429K$278K$0$0
Income Before Tax-$131M-$14M-$233M-$45M-$28M
Tax Expense$0-$88K-$4M$0-$10M
Net Income-$131M-$14M-$229M-$45M-$18M
Net Margin-165.1%-9.8%-153.8%-28.4%-9.6%
EPS (Diluted)$-2.04$-0.18$-2.82$-0.48$-0.14
EBITDA-$97M$11M-$25M-$24M-$15M
Shares Outstanding64M85M81M95M128M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms